(Q51643575)

8 April 2018

title

Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry. (English)

1 reference

8 April 2018

1 reference

Jun Zou

1

1 reference

8 April 2018

Shi-Dong Luo

series ordinal

2

1 reference

8 April 2018

Yu-Quan Wei

series ordinal

3

1 reference

8 April 2018

Sheng-Yong Yang

series ordinal

4

1 reference

8 April 2018

publication date

26 October 2010

1 reference

8 April 2018

published in

Molecular BioSystems

1 reference

8 April 2018

volume

7

1 reference

8 April 2018

issue

1

1 reference

8 April 2018

page(s)

169-179

1 reference

8 April 2018

Cell cycle, CDKs and cancer: a changing paradigm

cites work

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

The decision to enter mitosis: feedback and redundancy in the mitotic entry network

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Irreversible cell-cycle transitions are due to systems-level feedback.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Building a cell cycle oscillator: hysteresis and bistability in the activation of Cdc2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Systems-level dissection of the cell-cycle oscillator: bypassing positive feedback produces damped oscillations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Polo-like kinase 1 reaches beyond mitosis--cytokinesis, DNA damage response, and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Polo-like kinases: conservation and divergence in their functions and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Bora and the kinase Aurora a cooperatively activate the kinase Plk1 and control mitotic entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Polo-like kinase-1 is activated by aurora A to promote checkpoint recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

The impact of a negligent G2/M checkpoint on genomic instability and cancer induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Regulating mammalian checkpoints through Cdc25 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

CDC25 phosphatases in cancer cells: key players? Good targets?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Polo and Aurora kinases: lessons derived from chemical biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Computational systems biology of the cell cycle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Proteins, drug targets and the mechanisms they control: the simple truth about complex networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Dynamical effects of epigenetic silencing of 14-3-3sigma expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Targeting polo-like kinase 1 for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Discovery and development of aurora kinase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Cell cycle kinases as therapeutic targets for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Systems biology and combination therapy in the quest for clinical efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Therapeutically targeting ErbB3: a key node in ligand-induced activation of the ErbB receptor-PI3K axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

KEGG: kyoto encyclopedia of genes and genomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Reactome: a knowledgebase of biological pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Cyclin-dependent kinases and cell-cycle transitions: does one fit all?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Cyclin-dependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Plk1- and beta-TrCP-dependent degradation of Bora controls mitotic progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Regulation of DNA repair throughout the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Restarting the cell cycle when the checkpoint comes to a halt

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Systems biology: parameter estimation for biochemical models

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Optimization in computational systems biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Ensemble modeling for analysis of cell signaling dynamics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

An iterative identification procedure for dynamic modeling of biochemical networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Aurora-kinase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

A robustness-based approach to systems-oriented drug design.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Synergistic drug combinations tend to improve therapeutically relevant selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

A systems biology dynamical model of mammalian G1 cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Logical modelling of cell cycle control in eukaryotes: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Robust, tunable biological oscillations from interlinked positive and negative feedback loops.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Network motifs: theory and experimental approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Principles of cancer therapy: oncogene and non-oncogene addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

Targeting the cancer kinome through polypharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FC0MB00004C

21 January 2018

Identifiers

DOI

10.1039/C0MB00004C

1 reference

8 April 2018

1 reference

8 April 2018